DNA study of bladder papillary tumours chemically induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in Fisher rats

International Journal of Experimental Pathology

Volumn 88, Issue 1, 2007, Pages 39-46

  Oliveira, Paula A ^a   Adega, Filomena ^b   Palmeira, Carlos A ^c,d   Chaves, Raquel M ^b   Colaço, Aura A ^a   Guedes Pinto, Henrique ^b   De La Cruz P, Luis F ^e   Lopes, Carlos A ^c,f  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^c PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^d UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^e UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^f UNIVERSITY OF PORTO   (Portugal)

Author keywords

Chromosome rearrangements; DNA study; Image cytometric analysis; Papillary carcinomas; Rats

Indexed keywords

CELL NUCLEUS DNA; DRINKING WATER; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE;

ANEUPLOIDY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLADDER PAPILLOMA; CANCER GRADING; CELL POPULATION; CONTROLLED STUDY; CYTOGENETICS; DNA DETERMINATION; FEMALE; HISTOGRAM; IMAGE ANALYSIS; IMAGE CYTOMETRY; MARKER CHROMOSOME; NONHUMAN; PAPILLARY CARCINOMA; PLOIDY; PRIORITY JOURNAL; RAT; STRUCTURAL CHROMOSOME ABERRATION; TUMOR CELL CULTURE; TUMOR GROWTH; UROTHELIUM;

ANIMALS; BUTYLHYDROXYBUTYLNITROSAMINE; CARCINOGENS; CARCINOMA, PAPILLARY; CHROMOSOME ABERRATIONS; CYTOGENETICS; DNA, NEOPLASM; FEMALE; NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED F344; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 33846460059     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2006.00517.x     Document Type: Article

References (38)

1. Ariel I., Ayesh S., Gofrit O. et al. (2004) Gene expression in the bladder carcinoma rat model. Mol. Carcinog. 41, 69-76.
2. Balakrishnan S., Payawal J., Schuler M.J., Hasegawa L., Eastmond D.A. (2002) Enhancing the in vitro and in vivo detection of aneuploidy by fluorescence in situ hybridization with the use of bromodeoxyuridine as a proliferation marker. Mutat. Res. 521, 81-89.
3. Becci P.J., Thompson H.J., Strum J.M., Brown C.C., Sporn M.B., Moon R.C. (1981) N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids. Cancer Res. 41, 927-932.
4. Bergers E., Baak J.P., van Diest P.J. et al. (1997) Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project. Mod. Pathol. 10, 762-768.
5. Boorman G.A., Wood M., Fukushima S. (1994) Tumours of the urinary bladder. IARC Sci. Publ. 111, 383-406.
6. Buchumensky V., Klein A., Zemer R., Kessler O.J., Zimlichman S., Nissenkorn I. (1998) Cytokeratin 20: a new marker for early detection of bladder cell carcinoma? J. Urol. 160, 1971-1974.
7. Cai T., Margallo E., Nesi G., Giubilei G., Rizzo M., Bartoletti R. (2006) Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up. Oncol. Rep. 15, 213-219.
8. Cajulis R.S., Haines G.K., III, Frias-Hidvegi D., McVary K., Bacus J.W. (1995) Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study. Diagn. Cytopathol. 13, 214-223.
9. Chaves R., Santos S., Guedes-Pinto H. (2004) Comparative analysis (Hippotragini versus Caprini, Bovidae) of X-chromosome's constitutive heterochromatin by in situ restriction endonuclease digestion: X-chromosome constitutive heterochromatin evolution. Genetica 121, 315-325.
10. Chico D.E. & Listowsky I. (2005) Diverse expression profiles of glutathione-S-transferase subunits in mammalian urinary bladders. Arch. Biochem. Biophys. 435, 56-64.
11. Crawford E.D. (1996) Diagnosis and treatment of superficial bladder cancer: an update. Semin. Urol. Oncol. 14, 1-9.
12. Debiec-Rychter M., Zukowski K., Wang C.Y. (1989) Chromosomal characteristics and malignancy of urothelial cells from carcinogen-treated rats. J. Natl. Cancer Inst. 81, 361-367.
13. Duesberg P., Fabarius A., Hehlmann R. (2004) Aneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cells. IUBMB Life 56, 65-81.
14. Duesberg P., Li R., Fabarius A., Hehlmann R. (2005) The chromosomal basis of cancer. Cell. Oncol. 27, 293-318.
15. Epstein J.I., Amin M.B., Reuter V.R., Mostofi F.K. (1998) The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am. J. Surg. Pathol. 22, 1435-1448.
16. Fadl-Elmula I. (2005) Chromosomal changes in uroepithelial carcinomas. Cell Chromosome 4, 2-9.
17. Fukushima S., Murasaki G., Hirose M., Nakanishi K., Hasegawa R., Ito N. (1982) Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats. Acta Pathol. Jpn. 32, 243-250.
18. Haroske G., Baak J.P., Danielsen H. et al. (2001) Fourth updated ESACP consensus report on diagnostic DNA image cytometry. Anal. Cell. Pathol. 23, 89-95.
19. Huang Q., Yu C., Klein M., Fang J., Goyal R.K. (2005) DNA index determination with Automated Cellular Imaging System (ACIS) in Barrett's esophagus: comparison with CAS 200. BMC Clin. Pathol. 5, 1-10.
20. Ikemoto K., Furuya T., Matsuda K. et al. (2004) Multicolor FISH and cytometric analyses allow classification of urothelial carcinomas into two subtypes, low- and high-grade tumors. Int. J. Oncol. 25, 893-898.
21. Ioakim-Liossi A.G., Karakitsos P.J., Pantazopoulos D., Aroni K.G., Athanossiadou P. (1999) Image cytometric DNA analysis and proliferating cell nuclear antigen (PCNA) expression in transitional cell carcinoma of the bladder. Cancer Detect. Prev. 23, 401-407.
22. Khaled H.M., Aly M.S., Mokhtar N. (2004) Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis. Urol. Oncol. 22, 443-447.
23. Kunze E. (1979) Development of urinary bladder cancer in the rat. Curr. Top. Pathol. 67, 145-232.
24. Lee J.Y., Park Y.N., Uhm K.O., Park S.Y., Park S.H. (2004) Genetic alterations in intrahepatic cholangiocarcinoma as revealed by degenerate oligonucleotide primed PCR-comparative genomic hybridization. J. Korean Med. Sci. 19, 682-687.
25. Oliveira P.A., Palmeira C., Lourenco L., Lopes C. (2005) Evaluation of DNA content in preneoplastic changes of mouse urinary bladder induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. J. Exp. Clin. Cancer Res. 24, 207-214.
26. Oliveira P.A., Plameira C., Colaco A., De la Cruz P.L.F. and Lopes C. (2006) DNA content analysis, expression of Ki-67 and P53 in rat urothelial lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and treated with Mitomycin C and Bacillus Calmette-Guérin. Anticancer Res. 26, 2995-3004.
27. Pathak S., Multani A.S. (2006) Aneuploidy, stem cells and cancer. EXS 96, 49-64.
28. Perabo F.G., Willert P.L., Wirger A. et al. (2005) Preclinical evaluation of superantigen (staphylococcal enterotoxin B) in the intravesical immunotherapy of superficial bladder cancer. Int. J. Cancer 115, 591-598.
29. Raju U., Zarbo R.J., Kubus J., Schultz D.S. (1993) The histologic spectrum of apocrine breast proliferations: a comparative study of morphologyis and DNA content by image analysis. Hum. Pathol. 24, 173-181.
30. Reeder J.E., Cox C., Wheeless L.L., Flint A., Liebert M., Grossman H.B. (1997) Variability of DNA analysis by image cytometry. Bladder Tumor Marker Network. Cytometry 28, 176-180.
31. Santos L., Lameiras C., Afonso J. et al. (2003) Is DNA content alteration a consequence of proliferative and differentiation changes in urothelial bladder tumors? Acta Urol. 20, 9-17.
32. Santos S., Chaves R., Adega F., Bastos E., Guedes-Pinto H. (2006) Amplification of the major satellite DNA family (FA-SAT) in a cat fibrosarcoma might be related to chromosomal instability. J. Hered. 97, 114-118.
33. Schnerch D., Hasskarl J., Engelhardt M., Wasch R. (2006) Origin and role of aneuploidy in cancer. Dtsch. Med. Wochenschr. 131, 1747-1753.
34. Sen S., Zhou H., Zhang R.D. et al. (2002) Amplification/ overexpression of a mitotic kinase gene in human bladder cancer. J. Natl. Cancer Inst. 94, 1320-1329.
35. Stamouli M.I., Panani A.D., Ferti A.D. et al. (2004) Detection of genetic alterations in primary bladder carcinoma with dual-color and multiplex fluorescence in situ hybridization. Cancer Genet. Cytogenet. 149, 107-113.
36. Sudbo J., Kildal W., Risberg B., Koppang H.S., Danielsen H.E., Reith A. (2001) DNA content as a prognostic marker in patients with oral leukoplakia. N. Engl. J. Med. 344, 1270-1278.
37. Vecchione A., Sevignani C., Giarnieri E. et al. (2004) Inactivation of the FHIT gene favors bladder cancer development. Clin. Cancer Res. 10, 7607-7612.
38. van Velthoven R., Petein M., Oosterlinck W.J. et al. (1995) Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas. Hum. Pathol. 26, 3-11.